期刊文献+

辛伐他汀对肾性高血压大鼠血压和心肌肥厚的影响 被引量:2

Effects of simvastatin on blood pressure and cardiac hypertrophy in rats with renovascular hypertension
下载PDF
导出
摘要 目的:研究辛伐他汀对肾性高血压大鼠血压抑制及对其抗心肌肥厚的作用。方法:大鼠被随机分成3组:假手术组、模型组(双肾双颊)和治疗组(双肾双夹+辛伐他汀)。治疗组于模型制备后第3周予以辛伐他汀2 mg/(kg·d)通过饮水给药,其他两组自由饮水。给药连续3个月后各组进行心功能各项指标的测定。结果:模型组颈动脉舒张压、收缩压、平均压、左心室重/体重,左右心室重量比分别比假手术组增加61.56%、39.93%、38.25%、61.64%和46.02%(各组P<0.05)。辛伐他汀组的颈动脉舒张压、平均压、左心室重/体重和左右心室重量比分别比模型组减少11%、10.33%、11.53%和12.49%(各组P<0.05)。结论:辛伐他汀可部分抑制肾性高血压大鼠的血压及心肌肥厚。 Objective:To investigate the effects of simvastatin (SIM) on blood pressure and myocardial hypertrophy in rats with renovaseular hypertension. Methods:Rats were randomly divided into 3 groups: sham operation group, model group (bilateral ligation ) and treatment group (bilateral ligation plus simvastatin treatment). 2 mg/( kg ~ d) Simvastatin was administered through drinking water in the treatment group beginning from the 3rd week after modeling, the other two groups were allowed free access to water. The diastolic blood pressure (DP) , systolic blood pressure (SP) , mean arterial pressure (MAP) , left veutricular weight (LVW) / body weight (BW), left ventricular weight (LVW)/ right ventrieular weight (RVW) of each group were measured after 3-month SIM treatment. Results: DP, SP, MAP, LVW/BW, and LVW/RVW increased by 61. 56% , 39.93%, 38.25% , 61.64% and 46.02% ( P 〈 0.05 ) , respectively, in the model group compared with the sham operation group, and decreased by 11% , 10.33% , 11.53% and 12.49% (P 〈0.05) , respectively, in the SIM group compared with the model group. Conclusion: Simvastatin may partially suppress the blood pressure and cardiac hypertrophy in rats with renovascular hypertension.
出处 《广州医学院学报》 2011年第4期25-26,43,共3页 Academic Journal of Guangzhou Medical College
关键词 肾性高血压 心肌肥厚 辛伐他汀 renovascular hypertension cardiac hypertrophy simvastatin
  • 相关文献

参考文献8

二级参考文献29

  • 1王宇,杨美玲.红丝线草醇提水转溶物的降压作用[J].暨南大学学报(自然科学与医学版),1995,16(4):22-25. 被引量:13
  • 2文丹,杨琼.中老年高血压患者血管超负荷指数、脉压与左室质量指数相关性的比较[J].高血压杂志,2006,14(3):189-192. 被引量:7
  • 3顾德官 顾天华 等.实验性高血压大鼠的血压观察[J].上海第二医学院学报,1985,2:102-105. 被引量:33
  • 4中国高血压防治指南修订委员会.中国高血压防治指南(2005年修订版式).高血压杂志,2005,13:2-41. 被引量:3
  • 5MULIE G, CERASOLA G. The Metabolic syndrome and its relationship to hypertensive target organ damage [ J ]. J Clin Hypertens,2006,8 ( 3 ) : 195 - 201. 被引量:1
  • 6SCUTERI A, NAJJAR S S, MULLER D C, et al. Metabolic Syndrome amplifies the age-associated increases in vascular thickness and stiffness [ J ]. J Am Coll Cardiol, 2004,43 (8) :1388 - 1395. 被引量:1
  • 7OUSLIMANI N, PEYNET J, BONNEFONT-ROUSSELOT D. Mefformin decreases intracellular production of reactive oxygen species in aortic endothelial cells [ J ]. Metabolism,2005,54 ( 6 ) : 829 - 834. 被引量:1
  • 8SCHILLACI G, PIRRO M, VAUDO G, et al. Prognostic value of the metabolic syndrome in essential hypertension [J]. J Am Coll Cardiol, 2004,43(10) :1817 - 1822. 被引量:1
  • 9LEONCINI G, RATTO E, VIAZZI F, et al. Metabolic syndrome is associated with early signs of organ damage in nondiabetic,hypertensive patients [ J ] . Intern Med,2005 ,257 ( 5 ) :454 - 460. 被引量:1
  • 10FRANKLIN S S,WEBER M A. Measuring hypertensive cardiovascular risk : the vascular overload concept [ J ]. Am Heart J, 1994,128 (4) :793 - 803. 被引量:1

共引文献19

同被引文献14

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部